Rt. Stanko et al., PYRUVATE INHIBITS CLOFIBRATE-INDUCED HEPATIC PEROXISOMAL PROLIFERATION AND FREE-RADICAL PRODUCTION IN RATS, Metabolism, clinical and experimental, 44(2), 1995, pp. 166-171
In an effort to identity the effects of the 3-carbon compound pyruvate
on free radical production, we measured hepatic total peroxisomal B-o
xidation and catalase activity and the production of lipofuscin-like p
roducts in male Sprague-Dawley rats consuming an adequate diet supplem
ented with pyruvate, vitamin E, or the peroxisome proliferator and fre
e radical enhancer clofibrate for 22 days (n = 5 in each group). Clofi
brate feeding induced hepatomegaly, a fivefold increase in total perox
isomal p-oxidation activity, and a threefold increase in hepatic lipof
uscin-like products (P < .05). Pyruvate but not vitamin E inhibited th
e increase in liver size by 70% (P < .05). Both pyruvate and Vitamin E
completely inhibited clofibrate-induced increases in lipofuscin-like
products (P < .05). Pyruvate but not clofibrate or vitamin E increased
plasma concentrations of the nitric oxide metabolites nitrite and nit
rate (P < .05). We conclude that with clofibrate-induced peroxisomal p
roliferation and free radical production, pyruvate will inhibit peroxi
somal proliferation and free radical production, inhibit free radical-
induced lipid peroxidation, and enhance metabolism of nitric oxide. Co
pyright (C) 1995 by W.B. Saunders Company